Campaign tells real story of living with MS
Belfast Telegraph Tue, 25 Sep 2007 1:21 AM PDT
A leading multiple sclerosis charity has launched a new campaign aimed at drawing attention to the fact that Northern Ireland has the second highest level of the disease in the world, only slightly behind Scotland.

Health and science news from UC campuses and labs UC Newswire Tue, 25 Sep 2007 2:07 PM PDT Cell-surface sugar defects may trigger nerve damage in MS patients Sep 20, UCI -- Defects on cell-surface sugars may promote the short-term inflammation and long-term neurodegeneration that occurs in the central nervous system of multiple sclerosis patients, according to UC Irvine researchers.

Knopp Neurosciences Initiates Phase 1 Clinical Trial Of KNS-760704 In ALS Development Program
Medical News Today Tue, 25 Sep 2007 1:13 AM PDT
Knopp Neurosciences Inc. ("Knopp") announced the initiation of a Phase 1 clinical trial of KNS-760704, a small molecule therapy in development for the treatment of amyotrophic lateral sclerosis (ALS). This randomized, double-blind, placebo-controlled, single ascending dose study in healthy volunteers is being closely followed by a multiple ascending dose study in healthy subjects. [click link ...